The Polyprin Nail from Kaken Pharmaceutical Co. - targeted lacquer for stubborn nail fungus

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-28, 04:13. Details in the imprint.

The Polyprin Nail from Kaken Pharmaceutical Co. sits as a thin, glossy film on the toenail, with a faint chemical smell that fades as the lacquer dries. One brush stroke before bed, socks back on, lights out - that is the whole routine.

How Polyprin Nail is used

Polyprin Nail is a prescription nail lacquer formulated for onychomycosis, the stubborn fungal infection that discolors and thickens nails over months rather than days. The clear or slightly cloudy film forms a tight coat that patients leave on overnight.

Dermatologists typically instruct patients to file the affected nail once a week, clean it carefully and then apply a thin layer of Polyprin Nail once daily. Over several months the new nail growth should gradually push out the damaged, yellowed part of the plate.

The formulation and feel

Unlike simple cosmetic varnishes, Polyprin Nail uses a medicated polymer base that adheres strongly to the nail surface and slowly releases the active antifungal into the nail keratin. That tacky first layer, which feels slightly sticky for a few minutes, is part of the delivery system.

Once dry, users report that the coating feels smooth rather than thick, so the nail does not catch on socks or bedding in everyday life. For many patients this quiet, once-daily ritual is easier to maintain than multiple oral tablets with systemic side effects.

Why doctors still reach for it

Tokyo-based dermatology specialist Dr. Hiroshi Sato describes Polyprin Nail as a steady workhorse for mild to moderate nail fungus, particularly in older patients with other medications. He values that the treatment remains local and avoids drug interactions in the liver.

In Japanese outpatient clinics, doctors often combine Polyprin Nail with careful nail trimming and advice on foot hygiene. For patients with early-stage disease this combination can avoid the need for systemic antifungal tablets, which require blood tests and closer monitoring.

Position in Kaken’s portfolio

Kaken Pharmaceutical has built much of its reputation in dermatology, with a focus on topical and local therapies that fit into everyday routines. Polyprin Nail sits alongside other skin and nail products that target chronic conditions rather than short-lived infections.

For retail investors, the product illustrates how a relatively narrow indication can still support a robust, recurring revenue stream when adherence is high and treatment courses run for several months per patient.

Context and share listing

All told, Polyprin Nail underlines Kaken Pharmaceutical’s consistent focus on practical, locally acting treatments that fit into the daily lives of patients who might never enter a large university hospital. Its quiet success contributes to the company’s image as a specialist rather than a broad-line pharma giant.

Kaken Pharmaceutical shares with ISIN JP3292200007 are listed on the Tokyo Stock Exchange, where the company is followed mainly by Japanese institutional investors and niche healthcare funds abroad.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.